Cytokines in kidney disease: the role of transforming growth factor-beta - PubMed (original) (raw)

Cytokines in kidney disease: the role of transforming growth factor-beta

W A Border et al. Am J Kidney Dis. 1993 Jul.

Abstract

Cytokines such as transforming growth factor-beta (TGF-beta) are peptide factors that regulate embryogenesis, development, inflammation, tissue repair, and carcinogenesis. Growing evidence indicates that dysregulation of cytokine actions may underlie the pathogenesis of serious autoimmune, degenerative, and fibrotic diseases. Studies in a model of acute mesangial proliferative glomerulonephritis show that overproduction of TGF-beta is the cause of pathologic accumulation of extracellular matrix in the nephritic glomeruli. Transforming growth factor-beta acts to increase matrix production, inhibit matrix degradation, and modulate matrix receptors in the glomerulonephritic rats. It may also play a role in the glomerular matrix build-up that is a central feature of diabetic nephropathy. Elevated expression of TGF-beta mRNA and TGF-beta protein were found in the glomeruli of diabetic rats along with increased levels of proteoglycans and other matrix components that are known to be induced by TGF-beta. The study of human diabetic glomeruli has also showed markedly elevated levels of TGF-beta protein. Glomeruli from normal kidneys and nonprogressive kidney disorders were negative. The striking ability of TGF-beta to cause exuberant matrix formation may be due to the fact that TGF-beta can induce its own production by resident cells at a site of injury. Thus, the potential for TGF-beta to do harm may be due to this autoinduction mechanism whereby TGF-beta expression can become chronic, creating a vicious circle. As the role that TGF-beta plays in chronic fibrotic diseases becomes better understood, it is likely that TGF-beta inhibitors will become important future drugs for treating these conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

• Transforming growth factor-beta and the pathogenesis of glomerular diseases.
  Border WA. Border WA. Curr Opin Nephrol Hypertens. 1994 Jan;3(1):54-8. doi: 10.1097/00041552-199401000-00007. Curr Opin Nephrol Hypertens. 1994. PMID: 7850412 Review.
• Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
  Border WA, Ruoslahti E. Border WA, et al. Cell Differ Dev. 1990 Dec 2;32(3):425-31. doi: 10.1016/0922-3371(90)90059-6. Cell Differ Dev. 1990. PMID: 2099240 Review.
• Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
  Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Yu, Pierschbacher MD, Ruoslahti E. Border WA, et al. Nature. 1992 Nov 26;360(6402):361-4. doi: 10.1038/360361a0. Nature. 1992. PMID: 1280332
• In vivo interactions of TGF-beta and extracellular matrix.
  Noble NA, Harper JR, Border WA. Noble NA, et al. Prog Growth Factor Res. 1992;4(4):369-82. doi: 10.1016/0955-2235(92)90017-c. Prog Growth Factor Res. 1992. PMID: 1340215 Review.

Cited by

• Renal biomarkers in cats: A review of the current status in chronic kidney disease.
  Kongtasai T, Paepe D, Meyer E, Mortier F, Marynissen S, Stammeleer L, Defauw P, Daminet S. Kongtasai T, et al. J Vet Intern Med. 2022 Mar;36(2):379-396. doi: 10.1111/jvim.16377. Epub 2022 Feb 26. J Vet Intern Med. 2022. PMID: 35218249 Free PMC article. Review.
• Transforming growth factor beta (TGF-β) is activated by the CtBP2-p300-AP1 transcriptional complex in chronic renal failure.
  Zhou P, Wan X, Zou Y, Chen Z, Zhong A. Zhou P, et al. Int J Biol Sci. 2020 Jan 1;16(2):204-215. doi: 10.7150/ijbs.38841. eCollection 2020. Int J Biol Sci. 2020. PMID: 31929749 Free PMC article.
• Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor β1.
  Lawson JS, Syme HM, Wheeler-Jones CPD, Elliott J. Lawson JS, et al. BMC Vet Res. 2018 Mar 9;14(1):76. doi: 10.1186/s12917-018-1387-2. BMC Vet Res. 2018. PMID: 29523136 Free PMC article.
• ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway.
  Jiang M, Zhang H, Zhai L, Ye B, Cheng Y, Zhai C. Jiang M, et al. Lipids Health Dis. 2017 Nov 16;16(1):216. doi: 10.1186/s12944-017-0611-6. Lipids Health Dis. 2017. PMID: 29145851 Free PMC article.
• Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice.
  Cho HS, Kim JH, Jang HN, Lee TW, Jung MH, Kim TH, Chang SH, Park DJ. Cho HS, et al. Sci Rep. 2017 Apr 5;7:46065. doi: 10.1038/srep46065. Sci Rep. 2017. PMID: 28378840 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal